Are you a fan of penny stocks and are constantly on the lookout for new ones? Out there, you’ll find an abundance to pick from, but most importantly it’s key to know how to accomplish doing so.
It can be intimidating at first as new penny stock ideas pop up all the time. Some may just be flash in the pan. Maybe you came across a social media post or a forum that is telling you that a particular stock is the “Next Big Thing.” Plus, there are several self proposed penny stock gurus out that will tell you that they can’t miss.
It’s important that you, as a trader, are able to navigate the markets on your own and can see through any misinformation that is circulating the web. Anybody can follow others, but can you do what you need to do on your own? Can you maneuver through all the information and take out the useful while leaving behind the useless? Well, for starters, you’re reading this article so you’re off to a good start.
Read Here: 3 Small Cap Stock Profiles To Watch Heading Into June
With so much news coming through on daily basis, you’ll need to sit down and pour through as much as possible to figure out what’s what. You’ve seen all the COVID-19 news and potential cures, etc. You’ve also now see the SpaceX and protesting/rioting news. How much of that will be an influence for specific penny stocks. News can be vital to penny stock as it could become a catalyst for a potential breakout. Check out these 3 penny stocks with major recent news.
Your No. 1 Small Cap Stock With Recent Major News: MoneyGram International, Inc.
MoneyGram International, Inc. (Nasdaq: MGI), together with its subsidiaries, provides money transfer services in the United States and internationally. The company operates through two segments, Global Funds Transfer and Financial Paper Products. The Global Funds Transfer segment offers money transfer services and bill payment services primarily to unbanked and underbanked consumers. The Financial Paper Products segment provides money orders to consumers through its agents and financial institutions; and official check outsourcing services for financial institutions. This segment sells its money orders under the MoneyGram brand and on a private label or co-branded basis with retail and financial institution. The company also offers digital solutions, such as moneygram.com, mobile solutions, account deposit, and kiosk-based services.
According to Bloomberg, Western Union Co. is seeking to acquire MoneyGram International Inc. in a transaction that would bring together two of the largest U.S. providers of money-transfer services, according to a person familiar with the matter.
Western Union has made a takeover offer for MoneyGram, said the person, who asked not to be identified because the matter isn’t public. No decision has been made and Western Union could opt to proceed without a deal, the person said.
Representatives for Western Union and MoneyGram declined to comment.
The business has been in decline as more people use online payments. Financial-technology upstarts have taken aim at the industry, offering strong new competition to established companies. Meanwhile, policy makers are intent on trimming the fees associated with moving money around the world.
Your No. 2 Small Cap Stock With Recent Major News: Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. (Nasdaq: TENX), is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF).
Tenax Therapeutics, Inc. announced positive Phase 2 results for levosimendan for the treatment of patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF). In this 37 patient study, the primary efficacy analysis, pulmonary capillary wedge pressure (PCWP) during exercise did not demonstrate a statistically significant reduction from baseline. Levosimendan did demonstrate a statistically significant reduction in PCWP compared to baseline (p=<0.0017) and placebo (p=<0.0475)when the measurements at rest, with legs up and on exercise were combined. Levosimendan also demonstrated a statistically significant improvement in 6-minute walk distance (6MWD) as compared to placebo (p=0.0329).
Dr. Stuart Rich, Professor of Medicine at the Bluhm Cardiovascular Institute at Northwestern University commented “Levosimendan is the first drug to ever show a favorable mechanism of action with biventricular effects in patients with PH-HFpEF. The consistency of the hemodynamic data and improvement in 6-minute walk demonstrates that levosimendan has great promise as a treatment for PH-HFpEF which has a serious unmet need. The favorable safety profile, especially the absence of any proarrhythmic effects, supports the further development with a phase 3 trial.”
Your No. 3 Small Cap Stock With Recent Major News: Westwater Resources, Inc.
Westwater Resources, Inc. (Nasdaq: WWR) operates as a diversified energy materials development company. The company’s principal project is the Coosa graphite project covering an area of approximately 41,964 acres situated in east-central Alabama. It also holds interest in three lithium brine exploration projects, which include Columbus Basin project in western Nevada; the Railroad Valley project in east-central Nevada; and the Sal Rica Project in northwestern Utah. It addition, the company holds interest in various uranium projects in New Mexico and Texas.
Westwater Resources, Inc. announced today that independent testing of its ULTRA-PMG™ battery graphite material has shown outstanding resistivity values as a conductive additive.
Christopher M. Jones, President and Chief Executive Officer, said, “This milestone achievement is a critical step in developing our battery graphite business. We have shown that one of the key products in our business plan – purified micronized graphite (ULTRA-PMG™) – can be produced using proprietary processes that we intend to utilize in our pilot program later this year. Successful performance testing demonstrates that we can manufacture our ULTRA-PMG™ as a premium-grade, conductive enhancement material for all types of batteries at larger scale.”
Westwater’s ULTRA-PMG™ product has been produced by laboratory-scale equipment simulating the full-scale processing flowsheet. Westwater has been working with Dorfner AnzaPlan in Germany to commercialize processing technology to produce various sizes of ULTRA-PMG™ products. Samples from Dorfner were sent to Polaris Laboratories, an independent laboratory in the United States, for testing to evaluate the performance of the product. This testing consisted of resistivity testing utilizing “4T sensing”, standard for measuring resistivity for the international battery industry. The 4T sensing testing method measures the performance of a sample accurately by using separate pairs of current carrying and voltage sensing electrodes.
